Naproxcinod

N/A

Report date: 2022/07/06 17:25:46
NME

Base Information

Drug NameNaproxcinod
Drug Alias NameNitronaproxen萘普西诺Naproxen nitroxybutyl esterNO-naproxenHCT-3012 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-1 inhibitorsCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2Cyclooxygenase-1
Therapy Area/IndicationsHypertensionRenal InsufficiencyLiver Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNicox
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNicox
Active IndicationsN/A
Inactive IndicationsHypertensionRenal InsufficiencyLiver Diseases +[5] 

Other Information

ATC CodeM01AE18
Related LinksWikipediaKEGG